| Application no. and date | 15807916.0 (espacenet) (Federated) (European Patent Register), 20151210 | | Patent/reg. no. and date | DK/EP 3256125, 20220126 | | Publication date | 20171220 | | Priority no. and date | WO PCT/EP2014/077469, 20141211, WO PCT/EP2015/058202, 20150415 | | EP pub. no. and date |
EP 3256125 20171220 | | Effective date | | | Applicant/owner | Actelion Pharmaceuticals Ltd, Gewerbestrasse 16
4123 Allschwil, CH | | Applicant ref. no. | P79227DK01 | | Inventor | HOCH, Matthias, 22 Orchard Close
Harston
Cambridge
Cambridgeshire CB22 7PT, GB,
DINGEMANSE, Jasper, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil, CH,
KRAUSE, Andreas, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/426 (2006.01) , A61P 1/00 (2006.01) , A61P 1/04 (2006.01) , A61P 11/02 (2006.01) , A61P 11/06 (2006.01) , A61P 13/12 (2006.01) , A61P 17/00 (2006.01) , A61P 17/06 (2006.01) , A61P 19/02 (2006.01) , A61P 25/00 (2006.01) , A61P 27/02 (2006.01) , A61P 3/10 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) , A61P 37/06 (2006.01) | | Title | DOSERINGSREGIMEN FOR PONESIMOD, EN SELEKTIV S1P1-RECEPTORAGONIST | | Int. application no. | EP2015079208 | | Int. publication no. | WO2016091996 | | Related patent (certificate) | CA 2022 00026 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
